Showing 1781-1790 of 6064 results for "".
Skin Reactions: Understanding New Drug Adverse Effects
https://practicaldermatology.com/conferences/aad-summer-2021/skin-reactions-understanding-new-drug-adverse-effects/19975/In addition to needing to stay abreast of new drugs in dermatology, it's important for dermatologists to stay informed about new medications that come to market in general. Vinod Nambudiri, MD, MBA says there are often dermatology-related adverse events that need to be managed. He discusses new cancPhysician Spotlight: Brian Adams, MD, MPH
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-brian-adams-md-mph/23534/Update on COVID-19 Vaccines and Dermal Fillers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/update-on-covid-19-vaccines-and-dermal-fillers/23451/CSF faculty discuss risks of delayed facial swelling in filler patients following COVID-19 vaccination.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-11/23225/Physician Spotlight: Murad Alam, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-murad-alam-md/23172/Antioxidants and Skin Cancer Risk: A Look at Vitamins A and B
https://practicaldermatology.com/topics/skin-cancer-photoprotection/antioxidants-and-skin-cancer-risk-a-look-at-vitamins-a-and-b/23106/There is some evidence to suggest that higher intake of these antioxidants may reduce skin cancer risks.Prospective Analysis: PRP Post-Mohs; Physician Debt Insights
https://practicaldermatology.com/youngmd-connect/resident-resource-center/propsective-analysis-prp-post-mohs-physician-debt-insights/23038/New OTC Topicals Target Hyperpigmentation, Melasma
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-otc-topicals-target-hyperpigmentation-melasma/22081/There's a new and expanding menu of options to improve uneven tone, proving that OTCs can provide benefit for a vexing concern.New in My Practice Rx: Seysara (sarecycline)
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-rx-seysara-sarecycline/20810/Approval for Evolus; Remembering Vic Narurkar, MD
https://practicaldermatology.com/topics/practice-management/dermwiretv-approval-for-evolus-remembering-vic-narurkar-md/19553/The FDA has approved Jeuveau, the lead product from Evolus, Inc. David Moatazedi, President and CEO of Evolus, and Michael Jafar, Chief Marketing Officer at Evolus, comment on market potential for the new product.Twenty-eight percent of physicians say the prior authorization process required by heal